Company news

Cantargia AB news in 2026

Cantargia AB's news releases, calls and decks from 2026, newest first.

View company

Cantargia appoints Dr. Monic Stuart as Chief Medical Officer

October 26, 2026

Cantargia to Host Q2 2026 Interim Results Conference Call

August 4, 2026

Cantargia: Cantargia Announces Changes in Number of Shares and Votes

July 31, 2026

Cantargia Announces Changes in Number of Shares and Votes

July 31, 2026

Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC

June 26, 2026

Cantargia announces outcome in rights issue and resolves on a directed issue of warrants to Fenja Capital

June 23, 2026

Cantargia publishes Information Document regarding Rights Issue of Shares

June 5, 2026

Cantargia AB to Host Webcast Covering Rights Issue, Loan Agreement, and Strategic Priorities

May 28, 2026

Bulletin from the Annual General Meeting in Cantargia AB (publ)

May 21, 2026

Cantargia Publishes Interim Report for The First Quarter of 2026

May 19, 2026

Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML

April 27, 2026

Notice of Annual General Meeting in Cantargia AB (publ)

April 17, 2026

Cantargia Publishes Annual Report 2025

April 17, 2026

Cantargia to Participate at Van Lanschot Kempen's Life Sciences Conference

March 5, 2026

Cantargia to Participate in TD Cowen's Annual Healthcare Conference

February 23, 2026

Cantargia Publishes Full Year Report 2025

February 20, 2026

Invitation to the Presentation of Cantargia's Annual Results for 2025

February 6, 2026

Cantargia to Participate at Leerink Partners Global Healthcare Conference

January 28, 2026

Cantargia Reports First Patient Dosed in New US Investigator-Initiated Colorectal Cancer Study

January 23, 2026

Calls in 2026

Decks in 2026